Bristol-Myers Squibb Company (BMY)
NYSE · Healthcare
Bristol-Myers Squibb Company Total Assets 2007–2025
Bristol-Myers Squibb Company annual total assets history from 2008 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Bristol-Myers Squibb Company total assets as of December 31, 2025: 90.04B, a 2.77% decrease year-over-year.
- Bristol-Myers Squibb Company total assets for 2025 were 90.04B, a 2.77% decrease from 2024.
- Bristol-Myers Squibb Company total assets for 2024 were 92.60B, a 2.69% decrease from 2023.
- Bristol-Myers Squibb Company total assets for 2023 were 95.16B, a 1.72% decrease from 2022.
- Bristol-Myers Squibb Company total assets for 2022 were 96.82B.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Bristol-Myers Squibb Company Annual Total Assets (Millions of US $) | |
|---|---|
| 2025 | $90,038 |
| 2024 | $92,603 |
| 2023 | $95,159 |
| 2022 | $96,820 |
| 2021 | $109,314 |
| 2020 | $118,481 |
| 2019 | $129,944 |
| 2018 | $34,986 |
| 2017 | $33,551 |
| 2016 | $33,707 |
| 2015 | $31,748 |
| 2014 | $33,749 |
| 2013 | $38,592 |
| 2012 | $35,897 |
| 2011 | $32,970 |
Bristol-Myers Squibb Company Total Assets — FAQ
Bristol-Myers Squibb Company (BMY) total assets over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMY's total assets history?
The chart and table above show Bristol-Myers Squibb Company's total assets by year and by quarter, including the growth rate.